-
(S)-2-(3-(Benzo[c][1,2,5]thiadiazole-4-sulfonamido)thiophene-2-carboxamido)-5-guanidinopentanoic acid 2,2,2-trifluoroacetate
-
BD6300001210945-69-999%
-
¥557.010mg
-
2-(5-Hydroxy-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)acetic acid
-
BD00954919118555-82-198%
-
¥2740.050mg
-
(S)-N-((3R,6S,9S,15S,20aS)-6-((1H-Indol-3-yl)methyl)-3-(cyclohexylmethyl)-9-(3-guanidinopropyl)-1,4,7,10,16-pentaoxoicosahydropyrrolo[1,2-a][1,4,7,10,13]pentaazacyclooctadecin-15-yl)-2-acetamido-3-phenylpropanamide
-
BD01071920219639-75-599%
-
¥850.010mg
-
(2-(2,2-Diphenylethoxy)acetyl)-L-arginine 2,2,2-trifluoroacetate
-
BD007936041140525-25-299%
-
¥497.010mg
-
Bis[(2H-1,3-benzodioxol-5-yl)methyl][(1-butyl-2,4-diphenyl-1H-imidazol-5-yl)methyl]amine
-
BD01156646439571-48-998%
-
¥2960.050mg
-
2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-Imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid compound acetic acid salt
-
BD01302032N/A98%
-
¥1413.010mg
-
(E)-3-(Methylthio)-N-(2-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)ethyl)acrylamide
-
BD00983642138916-58-298%
-
¥1076.010mg
-
4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid hydrochloride
-
BD013114091646321-63-298%
-
¥716.010mg
-
Eculizumab
-
BD01181691219685-50-497%
-
¥2070.01mg
-
(S)-2-(5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carboxamido)-5-guanidinopentanoic acid
-
BD014592972411440-41-895%
-
¥1634.025mg
-
2-Carbamimidoylbenzo[b]thiophen-6-yl thiophene-2-carboxylate methanesulfonate
-
BD630545217099-44-099%
-
¥589.010mg
-
4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid
-
BD011195761644670-37-098%
-
¥3653.050mg
-
(2S,4R)-1-(2-(3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide
-
BD011594341903768-17-198%
-
¥1639.050mg
-
2-((4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-10-((1H-imidazol-5-yl)methyl)-19-((1H-indol-3-yl)methyl)-34-((2S,3S)-2-((R)-2-amino-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)-4-(((2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl)(methyl)carbamoyl)-25-(3-amino-3-oxopropyl)-7-(3-guanidinopropyl)-31-isopropyl-13,17-dimethyl-28-((1-methyl-1H-indol-3-yl)methyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decaazacyclopentatriacontan-22-yl)acetic acid x2,2,2-Trifluoroacetic acid salt
-
BD013145071789738-04-098%
-
¥999.025mg
-
Avdoralimab
-
BD016912042226393-85-595%
-
¥
-
Vilobelimab
-
BD016791452250440-41-495%
-
¥
-
Vesencumab
-
BD017194971205533-60-395%
-
¥
-
CP-289
-
BD025558691349637-14-495%
-
¥
-
Sutimlimab
-
BD015711392049079-64-198%
-
¥
-
Tesidolumab
-
BD016181441531594-08-795%
-
¥